oxazolidin-2-one has been researched along with selegiline in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callingham, BA | 1 |
| Bizière, K; Kan, JP; Mouget-Goniot, C; Steinberg, R; Worms, P | 1 |
| Dostert, P; Strolin Benedetti, M | 1 |
| Jarrott, B; Vajda, FJ | 1 |
| Greenshaw, AJ; Turkish, S; Yu, PH | 1 |
| Boucher, T; Dostert, P; Dow, J; Strolin Benedetti, M | 1 |
| Benedetti, MS; Fowler, CJ | 1 |
| Benedetti, MS; Dostert, P; Guffroy, C; Tipton, KF | 1 |
| Ancher, JF; Benedetti, MS; Sontag, N | 1 |
3 review(s) available for oxazolidin-2-one and selegiline
| Article | Year |
|---|---|
Some aspects of monoamine oxidase pharmacology.
Topics: Animals; Guinea Pigs; In Vitro Techniques; Male; Mesenteric Arteries; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Muscle, Smooth; Oxazoles; Oxazolidinones; Rats; Selegiline; Semicarbazides; Vas Deferens | 1986 |
Overview of the present state of MAO inhibitors.
Topics: Animals; Benzamides; Humans; Hydrazines; Isoquinolines; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Parkinson Disease; Phenethylamines; Piperidines; Selegiline; Structure-Activity Relationship | 1987 |
The current status of monoamine oxidase and its inhibitors.
Topics: Allylamine; Benzamides; Clinical Trials as Topic; Humans; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Selegiline | 1987 |
1 trial(s) available for oxazolidin-2-one and selegiline
| Article | Year |
|---|---|
The current status of monoamine oxidase and its inhibitors.
Topics: Allylamine; Benzamides; Clinical Trials as Topic; Humans; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Selegiline | 1987 |
6 other study(ies) available for oxazolidin-2-one and selegiline
| Article | Year |
|---|---|
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
Topics: Animals; Benzamides; Biogenic Amines; Brain; Clorgyline; Dopamine; Duodenum; Harmaline; Isoenzymes; Liver; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Pyridazines; Rats; Selegiline; Synaptosomes | 1987 |
Monoamine oxidase-B inhibition: a comparison of in vivo and ex vivo measures of reversible effects.
Topics: Animals; Drug Interactions; In Vitro Techniques; Male; Monoamine Oxidase; Motor Activity; Oxazoles; Oxazolidinones; Phenethylamines; Rats; Rats, Inbred Strains; Selegiline; Time Factors | 1988 |
Metabolism of the monoamine oxidase-B inhibitor, MD 780236 and its enantiomers by the A and B forms of the enzyme in the rat.
Topics: Animals; Biotransformation; Brain; Clorgyline; In Vitro Techniques; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Rats; Rats, Inbred Strains; Selegiline; Stereoisomerism | 1983 |
The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
Topics: Aging; Animals; Brain; Clorgyline; Dopamine; Isoenzymes; Kinetics; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Rats; Rats, Inbred Strains; Selegiline; Species Specificity | 1983 |
Partial or total protection from long-acting monoamine oxidase inhibitors (MAOIs) by new short-acting MAOIs of type A MD780515 and type B MD780236.
Topics: Animals; Brain; Clorgyline; Dose-Response Relationship, Drug; Female; Liver; Male; Monoamine Oxidase Inhibitors; Myocardium; Oxazoles; Oxazolidinones; Rats; Rats, Inbred Strains; Selegiline; Tranylcypromine | 1983 |
Monoamine oxidase inhibitors and histamine metabolism.
Topics: Animals; Clorgyline; Histamine; Iproniazid; Male; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Rats; Selegiline; Tranylcypromine | 1980 |